Perone Thomas Michael
SEC CIK 1771761 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | GC, Sec | 28.1K | — | — | 1 | 2024-02-22 | 2024-02-22 |
Most active insiders at OVID, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ALEXANDER MARGARET A. | Pres, CEO, Dir | — | $16.9K |
| 2 | Rona Jeffrey A | CBFO | — | $12.4K |
| 3 | Fitzgerald Kevin Joseph | Dir | — | — |
| 4 | Carter Charles Ross | CFO | — | — |
| 5 | Takeda Pharmaceuticals U.S.A., Inc. | 10% | — | — |
| 6 | Friedman Bart | Dir | — | — |
| 7 | LEVIN JEREMY M | Executive COB, Dir | — | — |
| 8 | PAPADOPOULOS STELIOS | Dir | — | — |
Perone Thomas Michael made no open-market trades at OVID in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-26 | 2024-02-22 | OVID | Ovid Therapeutics Inc. | Perone Thomas Michael | GC, Sec | A - Grant | $0.00 | +28.1K | 28.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations